Head CT dose varied 3.4-fold across protocols
A registry study found large dose differences among commonly used head-CT techniques, pointing to protocol optimization rather than a universal lowest-dose setting.
The 60-second version
A 904,209-scan registry found more than two-fold variation in size-adjusted head-CT dose across commonly used adult and pediatric protocols.
Key points
- The analysis separated adults from children and helical from axial scans, then clustered acquisition parameters with unsupervised machine learning.
- Mean adjusted dose varied by more than two-fold in all four groups and up to 3.4-fold; adult helical scans ranged from 372 to 998 mGy·cm.
- Lower-dose clusters often used lower tube current or voltage, but different parameter combinations could work.
- This is an observational dose study, not proof that one lowest-dose setting fits every diagnostic task.
Verdict. The strongest implication is for protocol review and standardization, with image quality and clinical judgment preserved.
What was measuredA registry of 904209 head CT scans
Researchers analyzed 904,209 routine head CT scans recorded between 2015 and 2021: 864,182 from adults and 40,027 from children. The scans came from 131 facilities in seven countries. Adults and children were separated, as were helical and axial acquisitions, creating four comparison groups.
What the model foundDose varied within familiar techniques
K-means clustering grouped scans by tube current, voltage, collimation, scan length and, for helical scans, pitch. After adjustment for patient head size, the mean dose differed by more than two-fold in every group and by up to 3.4-fold. In adult helical scans, the dose-length product ranged from 372 to 998 mGy·cm across clusters.
How to read itOptimization is a protocol problem
Lower-dose clusters generally used lower tube current or voltage, but no single setting won everywhere. The study suggests that departments can compare their routine protocols, find high-dose outliers and standardize well-tested lower-dose approaches while checking that image quality remains adequate.
| Study design | Retrospective scan-level analysis of an international CT dose registry. |
|---|---|
| Population | 864,182 adult scans and 40,027 pediatric scans; not a treatment trial. |
| Main metric | Patient-size-adjusted dose-length product and CTDIvol. |
| Clinical boundary | Radiation metrics do not establish diagnostic equivalence or future cancer risk. |
The actionable finding is not one magic dose. It is the large, reviewable spread among protocols that are already in routine use.
What to do with itKeep the scan justified and optimized
Patients should not treat the study as a reason to refuse a medically indicated CT or to demand one universal setting. The useful question is whether the radiology service reviews protocol variation and optimizes exposure for the diagnostic task, patient size and scanner.